Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001783908-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-02 | 2026-02-26 | JAZZ | Patil Neena M | EVP, CLO | M - OptEx | $127.23 | +51.0K | 73.5K | +227% | +$6.49M |
| DM | 2026-03-02 | 2026-02-26 | JAZZ | Patil Neena M | EVP, CLO | S - Sale+OE | $191.56 | -55.6K | 56.9K | -49% | -$10.65M |
| D | 2026-03-02 | 2026-02-26 | JAZZ | Patil Neena M | EVP, CLO | A - Grant | $0.00 | +10.1K | 78.5K | +15% | $0 |
| DM | 2026-03-02 | 2026-02-26 | JAZZ | Patil Neena M | EVP, CLO | M - OptEx | $0.00 | -51.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-02-26 | M | A | 875 | $113.10 | 57,737 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-02-26 | S | D | 875 | $192.07 | 56,862 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $192.0600 to $192.1100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 3 | Common | Ordinary Shares | 2026-02-26 | M | A | 27,084 | $137.12 | 83,946 | D | — | — | |
| 4 | Common | Ordinary Shares | 2026-02-26 | S | D | 15,555 | $190.28 | 68,391 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.9150 to $190.9000. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 5 | Common | Ordinary Shares | 2026-02-26 | M | A | 2,916 | $137.12 | 71,307 | D | — | — | |
| 6 | Common | Ordinary Shares | 2026-02-26 | S | D | 2,916 | $189.81 | 68,391 | D | — | — | (F4) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $189.7300 to $189.9150. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 7 | Common | Ordinary Shares | 2026-02-26 | A | A | 10,079 | $0.00 | 78,470 | D | — | — | |
| 8 | Common | Ordinary Shares | 2026-02-26 | S | D | 11,529 | $191.65 | 66,941 | D | — | — | (F6) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $191.3200 to $192.0600. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 9 | Common | Ordinary Shares | 2026-02-26 | S | D | 3,523 | $193.58 | 63,418 | D | — | — | (F7) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $193.2900 to $193.8400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 10 | Common | Ordinary Shares | 2026-02-26 | S | D | 1,061 | $190.00 | 62,357 | D | — | — | (F8) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.395 to $190.3700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 11 | Common | Ordinary Shares | 2026-02-26 | S | D | 549 | $190.80 | 61,808 | D | — | — | (F9) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $190.4100 to $191.2150. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 12 | Common | Ordinary Shares | 2026-02-26 | S | D | 1,784 | $191.88 | 60,024 | D | — | — | (F10) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $191.4750 to $192.4300. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 13 | Common | Ordinary Shares | 2026-02-26 | S | D | 1,009 | $192.79 | 59,015 | D | — | — | (F11) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $192.4600 to $193.4500. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 14 | Common | Ordinary Shares | 2026-02-26 | S | D | 197 | $193.60 | 58,818 | D | — | — | (F12) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $193.5300 to $193.6700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 15 | Common | Ordinary Shares | 2026-02-26 | M | A | 20,125 | $113.10 | 73,464 | D | — | — | |
| 16 | Common | Ordinary Shares | 2026-02-26 | S | D | 16,602 | $192.53 | 56,862 | D | — | — | (F1) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $192.1100 to $193.0100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 17 | Derivative | Incentive Stock Option (right to buy) | 2026-02-26 | M | D | 2,916 | $0.00 | 0 | D | $137.12 · — to 2029-08-07 | 2,916 Ordinary Shares | (F14) These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of July 29, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter. |
| 18 | Derivative | Incentive Stock Option (right to buy) | 2026-02-26 | M | D | 875 | $0.00 | 0 | D | $113.10 · — to 2030-02-26 | 875 Ordinary Shares | (F13) These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. |
| 19 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-02-26 | M | D | 20,125 | $0.00 | 0 | D | $113.10 · — to 2030-02-26 | 20,125 Ordinary Shares | (F13) These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. |
| 20 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-02-26 | M | D | 27,084 | $0.00 | 0 | D | $137.12 · — to 2029-08-07 | 27,084 Ordinary Shares | (F14) These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of July 29, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter. |